Posted on

FDA will attach warning of rare nerve syndrome to Johnson & Johnson’s COVID-19 vaccine

Alex Gorsky, Johnson & Johnson’s chief executive, said last month that he was still hopeful that the vaccine, which has been used in 27 countries so far, would help contain the pandemic overseas. The company has promised up to 400 million doses to the African Union. Separately, Covax, the global vaccine-sharing program, is supposed to receive hundreds of millions of doses.

Source: DreamAfrica LIVE (A DreamGalaxy Trusted Brand)